Original Research
Published on 08 Nov 2023
Development and characterization of narsoplimab, a selective MASP-2 inhibitor, for the treatment of lectin-pathway–mediated disorders
in Molecular Innate Immunity
- 6,667 views
- 12 citations
Original Research
Published on 08 Nov 2023
in Molecular Innate Immunity
Editorial
Published on 07 Nov 2023
in Molecular Innate Immunity
Original Research
Published on 07 Nov 2023
in Molecular Innate Immunity
Editorial
Published on 07 Nov 2023
in Molecular Innate Immunity
Editorial
Published on 02 Nov 2023
in Molecular Innate Immunity
Review
Published on 02 Nov 2023
in Molecular Innate Immunity
Original Research
Published on 31 Oct 2023
in Molecular Innate Immunity
Original Research
Published on 30 Oct 2023
in Molecular Innate Immunity
Original Research
Published on 30 Oct 2023
in Molecular Innate Immunity
Original Research
Published on 27 Oct 2023
in Molecular Innate Immunity
Original Research
Published on 27 Oct 2023
in Molecular Innate Immunity
Clinical Trial
Published on 27 Oct 2023
in Molecular Innate Immunity
Original Research
Published on 27 Oct 2023
in Molecular Innate Immunity
Review
Published on 27 Oct 2023
in Molecular Innate Immunity
Review
Published on 26 Oct 2023
in Molecular Innate Immunity
Review
Published on 26 Oct 2023
in Molecular Innate Immunity
Original Research
Published on 26 Oct 2023
in Molecular Innate Immunity
Review
Published on 26 Oct 2023
in Molecular Innate Immunity
Original Research
Published on 26 Oct 2023
in Molecular Innate Immunity
Original Research
Published on 25 Oct 2023
in Molecular Innate Immunity
Original Research
Published on 25 Oct 2023
in Molecular Innate Immunity
Review
Published on 25 Oct 2023
in Molecular Innate Immunity
Original Research
Published on 25 Oct 2023
in Molecular Innate Immunity
Review
Published on 25 Oct 2023
in Molecular Innate Immunity